Advertisement
Incyte Corporation

Incyte Corporation (INCY) Stock Overview

Explore Incyte Corporation’s financial performance, market position, analyst ratings, and future outlook.

INCYNASDAQ
HealthcareBiotechnology
$108.53
$0.70(0.65%)
U.S. Market opens in 61h 40m
Advertisement

Incyte Corporation (INCY)

Meyka AI Score

Z

Key Financials

Market Cap21.7B
P/E Ratio15.14
EPS (TTM)$7.08
ROE0.29%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

INCY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Incyte Corporation (INCY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 71.05, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 15.14 and a market capitalization of 21.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.65%
5-Day Change
7.25%
1-Month Change
9.48%
3-Month Change
17.93%
6-Month Change
13.75%
Year-to-Date (YTD) Change
9.88%
1-Year Change
56.79%
3-Year Change
74.77%
5-Year Change
31.33%
All-Time (Max) Change
5688.27%

Contact Information

302 498 6700
1801 Augustine Cut-Off, Wilmington, DE, 19803

Company Facts

26,170 Employees
IPO DateNov 4, 1993
CountryUS
Actively Trading

Frequently Asked Questions